Extract

The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and minimum pharmacologically active dose of peginesatide in Healthy Volunteers.

Inclusion criteria

• Anemia ,chronic kidney disease ,Chronic renal failure ,Cancer

Links

• nct
• ictrp